NICALERT— 510(k) K021688

Substantially Equivalent

Nymox Pharmaceutical Corporation

FDA 510(k) clearance K021688 for NICALERT, Substantially Equivalent on 2002-10-18. Applicant: Nymox Pharmaceutical Corporation.

Clearance details

Applicant
Nymox Pharmaceutical Corporation
Product code
Code MRS
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Maywood, NJ, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.